Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes
- PMID: 7553595
- DOI: 10.1016/0165-4608(95)00057-v
Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes
Abstract
We report on the cytogenetic analyses of 158 cases of metastatic malignant melanoma, comprised of 63 cases with regional disease (RD) and 95 cases with distant (metastatic) disease (DD). Clonal structural abnormalities were identified in 126 (80%) cases and were significantly increased ( < 0.01 after adjusting for multiple comparisons) on chromosomes (in order of frequency of involvement) 1, 6, 7, 11, 9, and 3. Clustering of breakpoints occurred at 1p36, 1p22-q21, 6p11-q21, 9p, 11q23-qter, 13p (especially for cases with DD), and 19q13. The most common clonal numerical abnormalities, in a subset of 49 near-diploid cases were -10, -22, -9, +7, -19, and -Y. Analysis of chromosome segment gains and losses (CSRP) showed frequent loss of chromosomes 6 and 10, followed by equal rates of involvement of chromosomes 1, 7, and 9. Whole or segmental losses of chromosome 9 (especially 9p) correlate well with recent molecular genetic studies identifying putative suppressor genes, and are also likely important genetic abnormalities. However, based on the frequency of abnormalities in this large series of metastatic melanomas, it is likely that structural abnormalities of 1 and 6, and 10 are important in the pathogenesis of sporadic advanced melanoma.
Similar articles
-
Cytogenetic findings in 21 malignant melanomas.Cancer Genet Cytogenet. 1994 Oct;77(1):69-73. doi: 10.1016/0165-4608(94)90152-x. Cancer Genet Cytogenet. 1994. PMID: 7923087
-
Application of molecular cytogenetic techniques in a case study of human cutaneous metastatic melanoma.Cancer Genet Cytogenet. 2001 Dec;131(2):97-103. doi: 10.1016/s0165-4608(01)00539-8. Cancer Genet Cytogenet. 2001. PMID: 11750048
-
Cytogenetics of melanoma and nonmelanoma skin cancer.Adv Exp Med Biol. 2008;624:227-40. doi: 10.1007/978-0-387-77574-6_18. Adv Exp Med Biol. 2008. PMID: 18348460 Review.
-
Cytogenetics of human malignant melanoma and premalignant lesions.Cancer Genet Cytogenet. 1984 Apr;11(4):429-39. doi: 10.1016/0165-4608(84)90024-4. Cancer Genet Cytogenet. 1984. PMID: 6584203
-
Cytogenetics of melanoma and nonmelanoma skin cancer.Adv Exp Med Biol. 2014;810:160-81. doi: 10.1007/978-1-4939-0437-2_9. Adv Exp Med Biol. 2014. PMID: 25207365 Review.
Cited by
-
Regulation of mGluR1 expression in human melanocytes and melanoma cells.Biochim Biophys Acta. 2012 Nov-Dec;1819(11-12):1123-31. doi: 10.1016/j.bbagrm.2012.06.005. Epub 2012 Jul 5. Biochim Biophys Acta. 2012. PMID: 22771868 Free PMC article.
-
New approaches to the biology of melanoma: a workshop of the National Institutes of Health Pathology B Study Section.Am J Pathol. 2002 Nov;161(5):1949-57. doi: 10.1016/S0002-9440(10)64470-7. Am J Pathol. 2002. PMID: 12414540 Free PMC article. No abstract available.
-
Role of the G Protein-Coupled Receptor, mGlu1, in Melanoma Development.Pharmaceuticals (Basel). 2010 Aug 26;3(9):2821-2837. doi: 10.3390/ph3092821. Pharmaceuticals (Basel). 2010. PMID: 24619402 Free PMC article.
-
Gain of Chromosome 1q Perturbs a Competitive Endogenous RNA Network to Promote Melanoma Metastasis.Cancer Res. 2022 Sep 2;82(17):3016-3031. doi: 10.1158/0008-5472.CAN-22-0283. Cancer Res. 2022. PMID: 36052492 Free PMC article.
-
AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma.Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6597-602. doi: 10.1073/pnas.1007694108. Epub 2011 Apr 1. Proc Natl Acad Sci U S A. 2011. PMID: 21460252 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous